4
Changes in Ownership
Vera Therapeutics, Inc. Filed Acc 0001415889-24-023779
Director sold 16,476 shares at an average $42.26 ($696,233)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
SEIDENBERG BETH C · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-09-18 | Sale : show line 1 in the form 10b5-1 | −1,177 | $42.01 | $49,448 | 160,376 | D |
| 2024-09-18 | Sale : show line 2 in the form 10b5-1 | −1,476 | $42.00 | $61,992 | 4,012 | I |
| 2024-09-19 | Sale : show line 3 in the form 10b5-1 | −13,823 | $42.31 | $584,793 | 146,553 | D |
| Open-market sales · 16,476 sh · avg $42.26 · $696,233 | ||||||
Loading xslF345X05/form4-09202024_080929.xml…